Evidence map›Paper›PMID 37443173›Full record

ArticleCell death & disease2023

A Dhdds K42E knock-in RP59 mouse model shows inner retina pathology and defective synaptic transmission.

Mai N Nguyen, Dibyendu Chakraborty, Sriganesh Ramachandra Rao, Agnieszka Onysk, Mariusz Radkiewicz, Liliana Surmacz, Ewa Swiezewska, Eric Soubeyrand, Tariq A Akhtar, Timothy W Kraft and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Mai N Nguyen *Department of Optometry and Vision Science, Vision Science Research Center, School of Optometry, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID 0000-0001-5349-7880
Dibyendu Chakraborty *Department of Optometry and Vision Science, Vision Science Research Center, School of Optometry, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Sriganesh Ramachandra RaoResearch Service, VA Western New York Healthcare System, Buffalo, NY, 14215, USA.
Agnieszka OnyskInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 02106, Poland.
Mariusz RadkiewiczInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 02106, Poland.ORCID 0000-0002-8659-6516
Liliana SurmaczInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 02106, Poland.
Ewa SwiezewskaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, 02106, Poland.
Eric SoubeyrandDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, N1G2W1, Canada.
Tariq A AkhtarDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, N1G2W1, Canada.
Timothy W KraftDepartment of Optometry and Vision Science, Vision Science Research Center, School of Optometry, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
David M SherryDepartments of Cell Biology, Neurosurgery, and Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Steven J FlieslerResearch Service, VA Western New York Healthcare System, Buffalo, NY, 14215, USA.ORCID 0000-0002-2557-142X
Steven J PittlerDepartment of Optometry and Vision Science, Vision Science Research Center, School of Optometry, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. pittler@uab.edu.ORCID 0000-0002-8464-9303
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLUniversity of Alabama at Birmingham · USUniversity of Guelph · CAVA Western New York Healthcare System · USUniversity of Oklahoma Health Sciences Center · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
Short Term Adaptations in PhotoreceptorsR01EY023603 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRAFT, TIMOTHY W, SINCICH, LAWRENCE C · 2014 to 2022
$3.1M
Development and characterization of mouse models of RP59 DHDDS deficiencyR01EY029341 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FLIESLER, STEVEN J., PITTLER, STEVEN J · 2018 to 2021
$2.2M
Characterization of DHDDS RP59 Knockin Models of Retinitis PigmentosaF31EY032764 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NGUYEN, MAI N · 2021 to 2025
$198k
NCATS NIH HHS UL1 TR003096NEI NIH HHS F31 EY032764NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY023603NEI NIH HHS R01 EY029341
6 · The paper itself

Abstract

Retinitis pigmentosa (RP) defines a group of hereditary progressive rod-cone degenerations that exhibit a common phenotype caused by variants in over 70 genes. While most variants in the dehydrodolichyl diphosphate synthase (DHDDS) gene result in syndromic abnormalities, some variants cause non-syndromic RP (RP59). DHDDS encodes one subunit of the enzyme cis-prenyltransferase (CPT), which is required for the synthesis of dolichol (Dol), that is a necessary protein glycosylation cofactor. We previously reported the creation and initial characterization of a knock-in (KI) mouse model harboring the most prevalent RP59-associated DHDDS variant (K42E) to understand how defects in DHDDS lead to retina-specific pathology. This model exhibited no profound retinal degeneration, nor protein N-glycosylation defects. Here, we report that the Dol isoprenylogue species in retina, liver, and brain of the K42E mouse model are statistically shorter than in the corresponding tissues of age-matched controls, as reported in blood and urine of RP59 patients. Retinal transcriptome analysis demonstrated elevation of many genes encoding proteins involved in synaptogenesis and synaptic function. Quantitative retinal cell layer thickness measurements demonstrated a significant reduction in the inner nuclear layer (INL) and total retinal thickness (TRT) beginning at postnatal (PN) ∼2 months, progressively increasing to PN 18-mo. Histological analysis revealed cell loss in the INL, outer plexiform layer (OPL) disruption, and ectopic localization of outer nuclear layer (ONL) nuclei into the OPL of K42E mutant retinas, relative to controls. Electroretinograms (ERGs) of mutant mice exhibited reduced b-wave amplitudes beginning at PN 1-mo, progressively declining through PN 18-mo, without appreciable a-wave attenuation, relative to controls. Our results suggest that the underlying cause of DHDDS K42E variant driven RP59 retinal pathology is defective synaptic transmission from outer to inner retina.

Indexed as

Retinal DegenerationRetinitis PigmentosaAnimalsElectroretinographyMiceRetinaSynaptic Transmission

Identifiers

PMID37443173
PMCPMC10345138
OpenAlexW4384202159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.